-
Mashup Score: 25Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial - 2 month(s) ago
Though clinical outcomes were no different between sexes, there remains an opportunity for more-equitable treatment.
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 137“Food Is Medicine” Strategies for Nutrition Security and Cardiometabolic Health Equity: JACC State-of-the-Art Review - 2 month(s) ago
Abstract ”Food Is Medicine” (FIM) represents a spectrum of food-based interventions integrated into health care for patients with specific health conditions and often social needs. Programs include…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 126“Food Is Medicine” Strategies for Nutrition Security and Cardiometabolic Health Equity: JACC State-of-the-Art Review - 2 month(s) ago
Abstract ”Food Is Medicine” (FIM) represents a spectrum of food-based interventions integrated into health care for patients with specific health conditions and often social needs. Programs include…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 6
∗Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 524A, Baltimore, Maryland 21287, USA. E-mail: E-mail Address: [email protected] Published by Elsevier on Behalf of The American College of Cardiology Foundation. Published online April 12,
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 1
Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, alleviated heart failure symptoms in patients with obesity, according to a late-stage trial that adds to the drug’s potential benefits.
Source: www.bloomberg.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function - 8 month(s) ago
The gains come amid positive shifts for CRP and NT-proBNP, suggesting more than weight loss is at play, the PI says.
Source: www.tctmd.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Speaking to @TCTMD abt STEP HF, #ACCPrev Chair @DrEugeneYang was positive but cautioned, "On the other hand, from the perspective of risk-benefit & cost-effectiveness, this study doesn't address that." https://t.co/fRnz1T95nC #ESCCongress
-
-
Mashup Score: 0
The ACC’s Prevention of Cardiovascular Disease Member Section and Leadership Council is the home for prevention professionals within the ACC, advocating for and advancing the priorities of the community.
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
New data on the heart benefit of an obesity drug from Novo Nordisk increases the chances of a pay-off for it and rival Eli Lilly, which have spent a record amount on U.S. lobbying to win government backing for the drugs, analysts and experts said.
Source: www.reuters.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 16
Research shows that heart attacks are becoming more prevalent among adults younger than 50—and the outcomes are worse for women. The good news is we know how to prevent them.
Source: www.nationalgeographic.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Three drugs could lower the risk of heart attacks, strokes and other complications for patients who can’t take or benefit enough from statins.
Source: WSJCategories: Cardiology News and Journals, Latest HeadlinesTweet
In the ISCHEMIA trial, women w/ chronic coronary disease received less-intense GDMT than men. “There shouldn’t really be these discrepancies,” #ACCPrev chair-elect Dr. @EugeniaGianos told @ToddNeale. Learn more: https://t.co/Wa6mNFeuBl @TCTMD